Late Onset Neonatal Sepsis
8
0
0
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
12.5%
1 terminated out of 8 trials
87.5%
+1.0% vs benchmark
25%
2 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (8)
Enrichment of Human Milk With Human and Bovine Milk-based Fortifiers for Very Preterm Infants: a Meta-analysis
Lactoferrin for Prevention of Sepsis in Infants
Neonatal Vancomycin Trial
Gut Priming With Oral Bovine Colostrum for Preterm Neonates; Randomized Control Trial
Effects of Delayed Cord Clamping in Very Low Birth Weight Infants
Bolus Versus Prolonged Infusion of Meropenem in Newborn With Late Onset Sepsis
Lactoferrin Prophylaxis in VLBW and Regulator T-cells
Effects of Oral Probiotic Supplementation on the Clinical Status of Very-low-birth-weight Preterm Neonates.